Epic Sciences wins federal grant to develop lung cancer test

01/25/2013 | GenomeWeb Daily News (free registration)

The NIH and the National Cancer Institute awarded Epic Sciences a Small Business Innovation Research grant to develop a test to detect and specify circulating tumor cells in lung cancer patients. Epic previously won a Phase I grant. The grants total $1.2 million.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT